We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
110 result(s) found, displaying 31 to 40
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIVALIRUDIN ANS bivalirudin (as trifluoroacetate) 250 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NITROPRUSSIDE SXP sodium nitroprusside 50mg/2mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NITROPRUSSIDE TLB sodium nitroprusside 50mg/2mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NITROPRUSSIDE RMB sodium nitroprusside 50mg/2mL concentrated injection vial.
-
Prescription medicine registrationActive ingredients: azacitidine.
-
Cancellation by sponsorRequested by Southern XP IP Pty Ltd
-
Cancellation by sponsorRequested by Southern XP IP Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LORAZEPAM SXP lorazepam 4 mg/1 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LORAZEPAM AJS lorazepam 4 mg/1 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LORAZE lorazepam 4 mg/1 mL solution for injection ampoule.